Technology Portfolio: Stem Cell Expansion - Arteriocyte Research and Development

Focused on Improving Patient Outcomes

Research & Development

Product and Technology

Company Information

Research Areas Research Collaborations

Company Products Technology Portfolio

Mission and Core Values Management Team Newsroom Contact Us Careers

Corporate Homepage

Cellular Expansion (NANEX)

The fundamental challenge in the development of any stem cell therapy is the difficulty in obtaining sufficient numbers of stem cells to create a therapeutically active dose. Because of the scarcity of stem cells in human tissue, efficient expansion strategies are necessary to consistently produce them in effective quantities. Arteriocyte’s NANEX technology (ex vivo expansion system) has been demonstrated to rapidly yield greater than a 250 fold increase of stem cells. The NANEX technology is in pre-clinical evaluation as a system that will enable production of stem cell therapies from significantly lower volume tissue harvests.

Arteriocyte, Inc.

Locations:

  Ohio Offices
  Cleveland
  Research & Development Center
  7100 Euclid Avenue
  Cleveland, Ohio 44103, USA
  Phone: 216-456-9640

  Massachusetts Offices
  Hopkinton
  Eastern US Manufacturing
  and Distribution Center
  45 South Street
  Hopkinton, MA 01748, USA
  Phone: 508-497-8950

  Utah Offices
  Salt Lake City
  Tissue Engineering Center
  1413 Center Drive, Ste 220
  Park City, UT 84098, USA
  Phone: 866-660-2674

  Maryland Offices
  Towson
  Malaria Initiative Center
  400 East Joppa Road
  Suite 416
  Towson, MD 21286, USA
  Phone: 866-660-2674

  E-mail: info@arteriocyte.com
  Phone: 1-866-660-AMSI(2674)
  Fax: 1-216-456-9641